Jasmine JohnsonLessons from the Alzheimer’s Disease Sequencing Project and subsequent DAWN study
By Greg Laub
Interview With Margaret Pericak-Vance, PhD
The DAWN study is an international, multi-site initiative to expand Alzheimer’s disease genetic research in underrepresented African ancestry populations and Latino groups.
In this exclusive MedPage Today video, Margaret Pericak-Vance, PhD, director of the John P. Hussman Institute for Human Genomics at the University of Miami Miller School of Medicine in Florida, discusses how the Alzheimer’s Disease Sequencing Project, which helped uncover the importance of including diverse populations in Alzheimer’s research, led to the subsequent DAWN study.
Following is a transcript of her remarks:
The goal of the Alzheimer’s Disease Sequencing Project was to sequence a large number of individuals to find the genetic variations — those with the disease and those who are cognitively unimpaired — to be able to identify genes that cause risk or even genes that are involved in prevention.
For the full video and transcript, please visit Med Page Today.